Prosorba column data

IMRE (Seattle) announced pilot trial results in 15 patients who had failed traditional drug therapies, showing significant reduction in symptoms (p<0.05) in a majority of the participants that persisted for the six-month follow-up.

As reported at the International Congress of Rheumatology in Bari, Italy, 9 patients had a positive clinical response at four months, 10 at five months, and 7 continued to have a positive clinical response at six months. One patient had complete remission under the Paulus criteria over the entire six-month study. ...